Literature DB >> 19688304

[Chronic pain management].

D Rothstein1, M Zenz.   

Abstract

Pain is one of the major complaints leading to doctor visits. Therefore basic knowledge of frequent pain diagnoses and possible treatment approaches is essential. Numerous medical and interventional therapeutic options are available for causal or symptomatic treatment of pain. The treatment of neuropathic pain is often difficult and demands special knowledge. Antidepressants like amitriptyline and anticonvulsive drugs are the first choice in these cases. Also interventional approaches are useful, such as spinal cord stimulation for angina pectoris. For the treatment of complex regional pain syndrome and phantom pain the use of mirror feed-back is a new effective method for pain relief. The only way to prevent from development of chronic pain is the early and effective treatment of acute pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688304     DOI: 10.1007/s00108-009-2474-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

Authors:  P H Coluzzi; L Schwartzberg; J D Conroy; S Charapata; M Gay; M A Busch; J Chavez; J Ashley; D Lebo; M McCracken; R K Portenoy
Journal:  Pain       Date:  2001-03       Impact factor: 6.961

2.  Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

Authors:  S Ahmedzai; D Brooks
Journal:  J Pain Symptom Manage       Date:  1997-05       Impact factor: 3.612

Review 3.  Plasticity and functional recovery in neurology.

Authors:  V S Ramachandran
Journal:  Clin Med (Lond)       Date:  2005 Jul-Aug       Impact factor: 2.659

4.  Breakthrough pain: definition, prevalence and characteristics.

Authors:  Russell K Portenoy; Neil A Hagen
Journal:  Pain       Date:  1990-06       Impact factor: 6.961

Review 5.  Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

Authors:  Kyriaki Mystakidou; Emmanuela Katsouda; Efi Parpa; Marinos L Tsiatas; Lambros Vlahos
Journal:  J Opioid Manag       Date:  2005 Mar-Apr

Review 6.  [Mirror feed-back - a new method for the treatment of neuropathic pain].

Authors:  A Schwarzer; S Glaudo; M Zenz; C Maier
Journal:  Dtsch Med Wochenschr       Date:  2007-10       Impact factor: 0.628

7.  Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.

Authors:  Guy Hans; Rainer Sabatowski; Andreas Binder; Irmgard Boesl; Peter Rogers; Ralf Baron
Journal:  Curr Med Res Opin       Date:  2009-05       Impact factor: 2.580

8.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

Authors:  C P Watson; N Babul
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

9.  Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Authors:  Y Harati; C Gooch; M Swenson; S Edelman; D Greene; P Raskin; P Donofrio; D Cornblath; R Sachdeo; C O Siu; M Kamin
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

Review 10.  [Multimodal pain therapy: principles and indications].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; I Gralow; D Irnich; K Klimczyk; G Müller; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.